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Abstract
Background: Gait and balance impairments lead to frequent falls and injuries in individuals with Huntington’s disease (HD).
Assistive devices (ADs) such as canes and walkers are often prescribed to prevent falls, but their efficacy is unknown. We
systematically examined the effects of different types of ADs on quantitative gait measures during walking in a straight path
and around obstacles.
Methods: Spatial and temporal gait parameters were measured in 21 subjects with HD as they walked across a GAITRite
walkway under 7 conditions (i.e., using no AD and 6 commonly prescribed ADs: a cane, a weighted cane, a standard walker,
and a 2, 3 or 4 wheeled walker). Subjects also were timed and observed for number of stumbles and falls while walking
around two obstacles in a figure-of-eight pattern.
Results: Gait measure variability (i.e., coefficient of variation), an indicator of fall risk, was consistently better when using the
4WW compared to other ADs. Subjects also walked the fastest and had the fewest number of stumbles and falls when using
the 4WW in the figure-of-eight course. Subjects walked significantly slower using ADs compared to no AD both across the
GAITRite and in the figure-of-eight. Measures reflecting gait stability and safety improved with the 4WW but were made
worse by some other ADs.
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Introduction
Considerable resources are spent on the provision of assistive
devices (ADs) for individuals with gait disturbances related to
neurologic disorders. However, there are no evidence-based
guidelines available upon which to base prescribing recommen-
dations. Devices that do not meet the needs of individuals are
unlikely to be used. In one survey, individuals with multiple
sclerosis were noted to have abandoned ADs 30% of the time
because of non-acceptance and 24.2% of the time because of
inappropriate device recommendation [1]. Potential risks associ-
ated with the prescription of ADs in Parkinson’s disease such as
worsening of freezing during gait have been noted [2]. Different
neurologic populations exhibiting distinct gait patterns are likely to
have different needs and responses to ADs.
Gait impairments [3–7] and decreased postural stability [8,9]
lead to balance loss and falls in individuals with Huntington’s
Disease (HD) [7]. Gait impairments demonstrated in subjects with
HD compared to age-matched controls include slower gait speed,
shorter and more variable stride length, a wide base of support,
decreased cadence, greater variability in stride time, swing time,
and double support time, and increased trunk sway both in the
anterior-posterior and medio-lateral directions [3–6,10]. Subjects
with HD also have greater postural sway in standing and
demonstrate delayed motor responses to unexpected balance
disturbances [8,9]. The greater variation in spatial and temporal
gait measures and increased postural sway are thought to be
related to impaired/disordered processing of sensory feedback
[11]. These balance and gait disorders lead to functional decline
and increase the risk for falls in individuals with HD.
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e30903Loss of independent walking is the greatest predictor of nursing
home placement in HD making treatment of gait disorders and fall
prevention essential aspects of care for affected individuals [12].
Clinicians typically prescribe AD’s such as canes and walkers in
the belief that AD’s will augment balance and prevent falls. To
date there is little research to support this belief or to guide
clinicians in their choices. AD selection should depend on
objective assessments of a person’s functional requirements and
physical capabilities [13]. Therefore, we compared spatial and
temporal gait measures while walking in a straight path and while
maneuvering around obstacles with and without using different
ADs. Based on previous findings in other patient populations and
our own observations regarding the effects of ADs on gait
characteristics [13–17], we hypothesized that the spatial and
temporal gait measures would be: 1) different when subjects
ambulated with an AD compared to without; 2) improved when
subjects ambulated with a walker with swivel wheels (i.e., three-
wheeled or four-wheeled) compared to walkers without swivel
wheels (i.e., standard and two-wheeled), and 3) improved when
subjects ambulated with a heavier cane compared to a standard
cane. We also hypothesized that gait speed would be improved
and there would be fewer losses of balance (i.e., stumbles or falls)
during figure-of-eight turns when subjects used walkers with swivel
wheels compared to no AD and other devices (i.e., canes and
walkers without swivel wheels). The identification of ADs that are
effective will enable clinicians to make more appropriate AD
prescriptions for individuals with HD.
Methods
Ethics Statement
The study was approved by the Ohio State University
Institutional Review Board. Written informed consent was
obtained from all subjects participating in the study.
Participants
Twenty-one volunteers were recruited from the Huntington’s
Disease Center of Excellence at the Ohio State University Medical
Center. Inclusion criteria were a clinical diagnosis of Huntington’s
disease confirmed by a neurologist; ability to comprehend complex
instructions as documented by ability to appropriately follow
instructions needed to perform the standard UHDRS neuropsy-
chiatric cognitive tests; ability to walk a minimum of 10 meters
without an AD or physical assistance; absence of any additional
central nervous system disorders; and absence of orthopedic and
peripheral neurological disorders affecting the lower extremities.
Individuals with HD have abnormal gait patterns compared to
healthy individuals. The purpose of this study was to examine the
effects of AD use on gait in individuals with HD; therefore subjects
were used as their own controls with the no AD condition as the
comparison or baseline condition.
Instrumentation
Spatial and temporal measures of gait were collected using the
GAITRite SystemH (CIR systems, Inc.: Havertown PA), a 4.88 m
electronic walkway with sensors arranged in a gridlike pattern to
capture footfall contacts. The application software (version 3.9)
processes the raw data into footfall patterns (see Figure 1) and
computes spatial and temporal parameters. The GAITRite
measures are valid and reliable in subjects with HD [18,19]. A
standard aluminum straight cane with offset handle (Harvey
Surgical Supply Corp., Flushing, NY), a heavy straight cane with
offset handle weighing 1 pound (Harvey Surgical Supply Corp.,
Flushing, NY), a standard adult walker (StW; Graham-Field
Health Products, Inc., Atlanta, GA), a two-wheeled walker (2WW)
with fixed front wheels (Medline Industries, Inc., Mundelein, IL), a
three-wheeled walker (3WW; Medline Industries, Inc., Mundelein,
IL) and a four -wheeled walker with front swivel casters (4WW;
Invacare Corporation, Elyria, OH) were utilized. All ADs were
adjusted by researchers who are licensed physical therapists to fit
subject height. These devices were chosen as they are the devices
most frequently used by individuals with HD who attend our
clinic. Both the 3WW and the 4WW were included as it would not
be valid to assume that these two devices function equivalently
given their very different designs (i.e., triangular versus square) and
both are popular devices in our clinic population.
Procedure
The UHDRS motor section was administered by a trained
investigator (SK) and demographic data including age, sex, and
number of years since symptom onset was obtained. Subjects
reported whether they had experienced any falls in the past 6
months, with a fall defined as unintentionally coming to rest on the
ground or other surface [20]. Leg length was measured as the
distance from the greater trochanter to the bottom of the heel of
the subject’s footwear so that spatial measures were normalized to
each subject’s height.
Prior to testing, a therapist trained each subject on the use of the
AD to be tested until the subject was observed to correctly and
safely use the device. Training time for each device was equivalent
to the time typically spent in our clinic to educate patients on
device use. Subjects then walked at a normal, comfortable pace
across the GAITRite walkway. Each subject performed 4 trials
using no AD and with each of the 6 different ADs. The first trial
under each condition was a practice trial. The GAITRite software
averaged the data from the remaining three trials for each
condition. Subjects were instructed to begin walking 2 meters
before and stop 2 meters beyond the edges of the walkway to allow
for acceleration and deceleration phases.
Figure 1. Footfall Patterns. Footfall pattern recordings in one
individual with HD under five conditions (A) no assistive device and
using a (B) cane, (C) standard walker, (D) two-wheeled walker or (E) four-
wheeled walker. The four-wheeled walker (E) produced a gait pattern
with the least variability.
doi:10.1371/journal.pone.0030903.g001
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subjects were timed using a stopwatch while they walked as fast as
they could in a figure-of-eight pattern around two chairs set 4 feet
apart under no AD and the 6 AD conditions. Each subject
performed the figure-of-eight task twice and the time to complete
the second trial was recorded. The investigators also recorded the
number of observed stumbles (loss of balance from which the
subject recovered without assistance) and falls (loss of balance for
which the investigator provided assistance to prevent the subject
from coming to the ground). The order of devices used was
randomized and subjects were allowed to sit and rest before and
between the GAITRite and figure-of-eight trials.
Coefficient of variation (CV) values were calculated for step
time, stride length, swing time and double support time to assess
the variability of gait measures across devices. For CV the average
time series of steps across 3 walkway trials was utilized to calculate
the mean and SD. Data for each of the gait measures and CVs
were analyzed using one-way repeated-measures ANOVA to
detect differences between the different walking conditions.
Multiple comparisons were adjusted for through use of post-hoc
Tukey tests. Significance was set a priori at ,0.05. All statistical
analysis was performed using SAS Version 9.2.
Results
Subjects were on average 49.3611 (25–66, range) years old,
were 4.763.9 (1–14) years post clinical diagnosis, had Total
Functional Capacity scores averaging 862.12 (4–11), had a mean
CAG repeat size of 44.0565.16 (37–58) and had Unified
Huntington’s Disease Rating Scale (UHDRS) motor sub-section
scores of 40.4614.4 (11–62) [21]. No subjects regularly utilized an
AD at the time of the study. All subjects exhibited gait and balance
deficits on the UHDRS and the GAITRite. Eight of the twenty-
one subjects (38%) reported having fallen at least once in the last 6
months.
Canes and walkers are sometimes weighted to improve handling
[21]. However, since heavy cane use did not alter gait measures as
compared to the standard cane, heavy cane data was excluded
from analysis. Therefore, only results for no AD and the 5
remaining devices are reported.
Gait measures across different assistive devices
Gait patterns varied markedly across the six conditions (Table 1,
Figure 1). In comparison to the no AD condition, walking with
ADs decreased mean velocity with the 4WW and 3WW being
statistically equivalent to the no AD condition (Figures 1 and 2A–
D). Walking with the 4WW and 3WW produced gait patterns with
the highest velocity, longest stride length, and narrowest base of
support (BOS) other than the no AD condition.In addition walking
with the 4WW produced the lowest percent time in double support
other than the no AD condition. In contrast, StW use produced
the most dissimilar gait pattern with significantly decreased
velocity and stride length and increased percent time spent in
double support compared to no AD. The standard cane and 2WW
also significantly reduced gait speed and stride length compared to
no AD. Although subjects exhibited good velocity and stride
length using the 3WW they had the highest percent time in double
support (59%), which was significantly greater than no AD (29%;
p,.05) and the 4WW (31%; p,.001). Walking with wheeled
walkers produced a significantly narrowed base of support (BOS;
p,0.05) compared with walking with no AD.
Gait measure variability across different walking
conditions
Compared to the other devices, walking with the 4WW
produced a gait pattern with the least variability in step to step
measures. (Table 2/Figure 3A–B) Walking with the StW and the
3WW produced more variability in gait measures compared to no
AD and several other devices (Table 1). Step time and stride length
variability (i.e., CVs) were significantly (p#.05) increased during
walking with the StW (Table 2, Figure 3). Walking with the 3WW
significantly increased (p#.05) step time, swing time, and double
support time variability (Table 2). Use of the2WW significantly
increased (p#.05) variability in step time and double support time.
Across the devices, the 4WW consistently produced low gait
measure variability.
Gait when maneuvering through a figure-of-eight
Walking speed was significantly faster with no AD than all
devices (p,.001) while walking with a StW was significantly slower
than all other conditions (p,.00001; Figure 4A). Use of the 4WW
resulted in faster completion times than all other devices except the
3WW and was significantly faster than the 2WW (p,.05). The
number of stumbles was highest with the StW. Stumbles were less
common with the 3WW and 4WW (Figure 4B), and in fact were
less frequent than with no AD. Three falls occurred in different
subjects while using no AD, the StW and the 3WW. Bumping the
Table 1. Gait measures across all walking conditions: mean, (standard deviation).
No AD Cane Standard Walker 2 Wheel Walker 3 Wheel Walker 4 Wheel Walker
Velocity (cm/s) 1.20 (0.07) 0.91*# (0.07) 0.60** (0.13) 0.91*# (0.06) 1.04# (0.06) 1.01# (0.06)
Stride Length (cm) 118.53 (4.37) 103.97*# (6.60) 81.46** (5.63) 105.50*# (5.29) 112.79# (3.5) 110.64# (4.71)
% Swing Time 35.7 (0.61) 34.38 (1.33) 29.32 (2.77) 33.23 (0.92) 30.75 (4.35) 36.84 (2.11)
% Double Support 29.18 (1.0) 34.66#‘ (2.04) 51.01*{1 (4.73) 36.9#‘ (3.05) 58.88*{1 (3.79) 31.07#‘ (5.05)
Base of Support (cm) 12.75 (4.47) 13.5{ (3.71) 11.52 (4.52) 10.58*{ (3.21) 9.55*{ (3.45) 10.59*{ (3.44)
Abbreviations: no AD, no assistive device; StW, standard walker; 2WW, two wheeled walker; 3WW, three wheeled walker; 4WW, four wheeled walker; CV, Coefficient of
Variation;
*significantly different than no AD at p,.05;
**significantly different than all other conditions at p,.05;
{significantly different than cane at p,.05;
#significantly different than StW at p,.05;
‘significantly different than 3WW at p,.05;
{significantly different from 2WW, 3WW, 4WW at p,.05;
1significantly different than 2WW, 4WW at p,.05.
doi:10.1371/journal.pone.0030903.t001
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Overall the 4WW performed better than any other device when
maneuvering around obstacles.
Discussion
Gait and mobility abnormalities significantly affect the inde-
pendence and quality of life of individuals with HD [12]. Although
ADs are routinely prescribed for neurological gait disorders, the
effects of different ADs on gait patterns have not been previously
analytically examined for specific neurological patient populations.
We have systematically examined the effects of different ADs on
spatial and temporal gait measures and maneuverability in
individuals with HD. Our findings illustrate the significant impact
that canes and walkers have on gait patterns of individuals with
HD both during walking on a straight path and around obstacles.
The 4WW produced a gait pattern with the least variability and
with the least impact on the individual’s ability to ambulate at their
usual walking speed. In addition, use of the 4 WW resulted in a
gait pattern that was safer than with no AD with reduced stumbles
and falls.
Compared to other devices, the 4WW produced a gait pattern
that was more similar to each individual’s spontaneous gait pattern
without an AD but with less variability and more stability. This
finding concurs with a study by Alkjaer et al. [17] which showed
that healthy middle aged females walked at equal speeds with no
AD and with a 4WW. Improved gait measures with the 4WW
over no AD included a narrowing of the base of support and
increased percent time in the swing phase. It is also noteworthy
that those using the 4WW had fewer stumbles and falls during
Figure 2. Gait Parameters. Comparison of gait parameters: (A) velocity, (B) stride length, (C) percent time in swing, and (D) percent time in double
support with standard deviation across 6 walking conditions: no AD, no assistive device; StW, standard walker; 2WW, two-wheeled walker; 3WW,
three-wheeled walker; 4WW, four-wheeled walker. * * significantly different than no AD at p,.05; **significantly different than all other conditions at
p,.05; { significantly different than cane at p,.05; # significantly different than StW at p,.05; ‘ significantly different than 3WW at p,.05; 1
significantly different than 2WW, 4WW at p,.05.
doi:10.1371/journal.pone.0030903.g002
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of the 4WW due to a wider base of support and more support
during turning than canes, Stw and no AD may underlie these
improvements. The 4WW also appears to provide greater ease of
use as it allows the individual to simply apply pressure with the
hands to propel it. The cane, StW, and 2WW require the user to lift
the device in time with their stepping whereas the 3WW and 4WWs
allow the person to push the device without lifting it. Ease of use is a
concern when prescribing ADs for individuals with HD who have
difficulties with learning sequences of movements and performing a
second task during walking [22]. Our observation that subjects
generally took longer to learn how to use the cane and StW
compared to the wheeled walkers would support this statement.
Gait with the 3WW was equivalent to the 4WW across several
measures but subjects spent more time in the stance phase with
this device than any other device and had significantly increased
gait variability. Increased stance time is a compensatory strategy
that people with gait instability often adopt to prevent falls [23,24].
Thus, the triangular design of the 3WW may provide less medial-
lateral stability than other wheeled walkers leading to unsteadiness
and increased stance time. This may be an important consider-
ation when prescribing ADs for patients with HD who have
increased trunkal sway related to chorea and dystonia. Other
possible explanations for prolonged stance time and greater gait
variability with 3WW use are that it’s triangular shape makes
maneuvering it a more challenging task cognitively or it’s
Figure 3. Coefficients of Variation. Comparison of mean coefficients of variation across six walking conditions: (A) step time and (B) stride length
coefficients of variation (CV) with standard deviation. Variability was consistently low when using the four-wheeled walker (4WW); no AD, no assistive
device; StW, standard walker; 2WW, two-wheeled walker; 3WW, three-wheeled walker; *significantly different than no AD at p,.05. * significantly
different than no AD at p,.05; { significantly different than cane at p,.05; # significantly different than StW at p,.05; ‘ significantly different than
3WW at p,.05; 1 significantly different than 2WW, 4WW at p,.05; Y significantly different than cane and 4WW at p,.05.
doi:10.1371/journal.pone.0030903.g003
Table 2. Coefficient of Variation of Gait measures across all walking conditions: mean, (standard deviation).
No AD Cane Standard Walker 2 Wheel Walker 3 Wheel Walker 4 Wheel Walker
Base of Support (cm) 12.75 (4.47) 13.5{ (3.71) 11.52 (4.52) 10.58*{ (3.21) 9.55*{ (3.45) 10.59*{ (3.44)
Step Time CV 6.47 (1.12) 13.77#‘ (2.82) 61.76*{1 (17.67) 17.30# (2.88) 51.98*Y (9.96) 6.98#‘ (8.64)
Stride Length CV 5.03 (0.82) 8.52# (1.66) 25.03*Y (6.78) 16.04 (4.10) 14.46 (5.39) 6.62# (1.03)
Swing Time CV 8.94 (1.51) 27.91 (15.29) 54.24 (20.95) 19.20‘ (2.94) 73.49*1 (12.66) 8.09‘ (9.41)
Double Support Time CV 9.51 (0.64) 19.99‘ (3.86) 31.89* (4.45) 29.27* (5.96) 38.06* Y (4.83) 11.42 # (10.52)
Abbreviations: no AD, no assistive device; StW, standard walker; 2WW, two wheeled walker; 3WW, three wheeled walker; 4WW, four wheeled walker; CV, Coefficient of
Variation;
*significantly different than no AD at p,.05;
{significantly different than cane at p,.05;
#significantly different than StW at p,.05;
‘significantly different than 3WW at p,.05;
significantly different from 4WW at p,.05;
significantly different from 2WW and 3WW at p,.05;
{significantly different from 2WW, 3WW, 4WW at p,.05;
1significantly different than 2WW, 4WW at p,.05;
Ysignificantly different than cane and 4WW at p,.05.
doi:10.1371/journal.pone.0030903.t002
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Examination of kinematic data which was collected during this
study but not yet analyzed may provide further insight.
The 2WW and StW produced the slowest gait speeds and
shortest stride lengths compared to the other ADs when walking
on a straight path. One explanation is that the smaller wheels on
the 2WW roll less smoothly than those on the 3WW and 4WWs.
Similar findings were reported by Mahoney et al. [14] who found
that stride length was decreased and time to walk an obstacle
course was increased with the 2WW as compared to the 3WW in
elderly subjects. The 2WW must be picked up when turning or
even when maintaining a straight path, whereas 3WW and 4WW’s
simply require the person to push on the devices. Individuals with
HD change path directions and may have to maneuver the 2WW
and StW more to keep going straight, thus explaining the slowing
and increased variability (i.e., coefficient of variations) of gait even
on the straight path. This is consistent with our finding that the
3WW and 4WW produced the highest velocities and stride lengths
compared to other ADs.
The variability in gait measures was lower with the 4WW than
any of the other devices. This may be clinically important, as
higher variability has been shown to correlate with increased falls
in the elderly [25,26] and those with Parkinson disease [4]. The
StW and 3WW’s exhibited the highest variability across all
measures followed by the 2WW. Canes performed better than the
standard, 2W and 3W walkers but had higher variability in all
measures than the 4WW. These findings indicate that subjects
adopted a safer and less variable gait when utilizing the 4WW.
Based on previous studies [25–27] low variability utilizing the
4WW would indicate a lower fall risk with this device than with the
StW, canes, 2W and 3W walkers.
Because individuals with HD demonstrate improved grasp and
arm movement when lifting and transporting a heavier object
compared to a lighter one, presumably due to increased
somatosensory feedback [28], we had hypothesized that using
the heavier cane would affect gait patterns differently compared to
the standard cane. However, we found no significant differences
between use of a standard cane and a weighted cane on gait
measures. One explanation for our finding is that the complexity
of coordinating walking with movement of a cane was so
challenging for many subjects that it overshadowed any benefits
from the additional weight. More research is needed to determine
whether weighting ADs improves gait patterns or function in
individuals with HD.
Maneuverability is an important factor to consider when
prescribing an AD as many individuals with HD fall when turning
or avoiding obstacles in their paths. The figure-of-eight course
utilized in this study appeared to be a sensitive measure of the
ability to make turns and safely maneuver around objects during
gait. As anticipated, subjects walked the fastest and had the fewest
number of stumbles when using the 3WW and the 4WW
compared to other ADs. This is not surprising since the walkers
with front swivel and rear wheels allow turning without additional
maneuvering of the device, whereas the 2WW must be picked up
during turning maneuvers. Lack of support during turns may
explain why there were more stumbles with the 2WW than either
of the other wheeled walkers. Of the three recorded falls, one
occurred with the 3WW, one with the StW, and one with no
AD.These findings indicate that subjects were able to make turns
and changes in direction in a more timely and safe manner with
the 4WW.
This is the first study in any neurological patient population that
systematically examines the effects of different ADs on spatial and
temporal gait measures and maneuverability; however, there are
several limitations to the study. Subjects in the study were not
regular users of ADs and thus device use was a novel task for these
individuals. However, subjects were trained on each device and
allowed to practice until they exhibited mastery of proper
technique and stated they felt comfortable using the device.
Nonetheless, some aspects of gait performance must be assumed to
be due to the novelty of utilizing a device. We attempted to control
for this limitation in several ways: 1) order of device use was
randomized across subjects and 2) novelty was a consistent factor
across all devices and thus did not affect any one device more than
another. Although subjects in this study were not regular AD
users, it should be noted that the subjects’ UHDRS motor scale
and TFC scores, and the high number of fallers indicated that they
had gait deviations that made them potential candidates to be
Figure 4. Figure of Eight Course. Comparison of mean time and stumbles on a figure of eight course: (A) mean time with standard deviation for
one lap around figure-of-eight course and (B) number of stumbles and number of individuals who stumbled walking in the figure-of-eight course
across conditions; no AD, no assistive device; StW, standard walker; 2WW, two-wheeled walker; 3WW, three-wheeled walker; 4WW, four-wheeled
walker. * significantly different than no AD at p,.001.
doi:10.1371/journal.pone.0030903.g004
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frequent fallers adopted the use of a 4WW immediately following
the study. Another limitation was that devices were being utilized
in an artificial environment rather than in a real world
environment. This limits our ability to fully assess device
performance across all possible aspects of use.
In conclusion, walking with a 4WW with front swivel wheels
produced a more efficient, consistent and safe gait pattern than
other commonly prescribed ADs in individuals with HD both on a
straight path and during turns. The greater stability, ease of use,
and maneuverability of the 4WW over other devices may account
for its better performance. These features are likely to make the
4WW more acceptable to patients and increase likelihood that the
device will be used. Unlike most gait disorders where increased age
is associated with increased falls, younger individuals with HD
motor symptoms tend to have a greater risk of falls than elderly
patients with HD with the same degree of motor impairment [29].
These younger individuals are more reluctant to accept the use of
an AD that might slow them down. Based on these findings, we
recommend that clinicians consider prescribing 4WWs over other
ADs for gait impairments and fall prevention for individuals with
HD. Future studies to examine other aspects of device use such as
performance in real world and outdoor environments are still
needed.
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